Literature DB >> 658145

Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex.

H H Harms, G Wardeh, A H Mulder.   

Abstract

The effects of adenosine and some related purines on the K+-induced release of 3H-noradrenaline from rat cerebral cortex slices were determined in a superfusion system. Adenosine and ATP caused a dose-dependent inhibition of 3H-NA release with a maximal effect of 35% at 10(-4) M. Theophylline, 10(-4) M, antagonized the inhibitory effect of adenosine. The results support the hypothesis that at least some of the central stimulant effects of the methylxanthines could be related to blockade of a purinergic inhibitory tone on noradrenergic synaptic output.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658145     DOI: 10.1016/0014-2999(78)90107-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture.

Authors:  R L MacDonald; J H Skerritt; M A Werz
Journal:  J Physiol       Date:  1986-01       Impact factor: 5.182

2.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

3.  Adenosine analogs mediating depressant effects on synaptic transmission in rat hippocampus: structure-activity relationships for the N6 subregion.

Authors:  T V Dunwiddie; T S Worth; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

4.  Adenosine and the endothelium-dependent modulation of 3H-noradrenaline release in the canine pulmonary artery.

Authors:  M J Vaz-da-Silva; S Guimarães; D Moura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

5.  Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.

Authors:  J Gonçalves; G Queiroz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  Release of norepinephrine and dopamine from brain vesicular preparations: effects of adenosine analogues.

Authors:  R P Ebstein; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1982-09       Impact factor: 5.046

7.  Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex.

Authors:  C Hollins; T W Stone
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

8.  Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; N Melman; X D Ji; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-04-21       Impact factor: 4.432

9.  Endogenous adenosine inhibits hippocampal CA1 neurones: further evidence from extra- and intracellular recording.

Authors:  H L Haas; R W Greene
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

Review 10.  Caffeine and anaerobic performance: ergogenic value and mechanisms of action.

Authors:  J K Davis; J Matt Green
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.